Biocerta Precision Diagnostics, Inc.
PrivateLast Round
Corporate Funding
Dec 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biocerta Precision Diagnostics, Inc. is a biotechnology company that has developed a functional drug-sensitivity platform to guide personalized cancer treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocerta Precision Diagnostics, Inc. Comparables
Compare Biocerta Precision Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SageMedic Corp. | 88% | |
| Travera | 87% | |
| Nagourney Cancer Institute | 83% |
Biocerta Precision Diagnostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 17, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Completed a corporate funding round.
Biocerta Precision Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access